PACS Group (PACS) Expected to Release Earnings on Tuesday

Key Points

• PACS Group is expected to report Q3 2026 results after Tuesday’s market close, with analysts forecasting $0.579 in earnings per share and $1.46 billion in revenue. The earnings call is scheduled for Wednesday, November 4.
• The company exceeded expectations in its previous quarter, reporting $0.63 EPS and $1.43 billion in revenue, above consensus estimates of $0.54 and $1.41 billion, respectively.
• Analyst sentiment remains positive, with five Buy ratings and two Holds producing a “Moderate Buy” consensus and an average price target of $58.80. However, insiders sold more than 1.3 million shares worth approximately $58.3 million during the last quarter.

PACS Group (NYSE:PACS - Get Free Report) is anticipated to announce its Q3 2026 results after the market closes on Tuesday, November 3rd. Analysts expect PACS Group to post earnings of $0.5790 per share and revenue of $1.46 billion for the quarter. Investors may review the information on the company's upcoming Q3 2026 earnings report for the latest details on the call scheduled for Wednesday, November 4, 2026 at 11:30 AM ET.

PACS Group (NYSE:PACS - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.54 by $0.09. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. The business had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. On average, analysts expect PACS Group to post $2.13 EPS for the current fiscal year and $2.57 EPS for the next fiscal year.

PACS Group Trading Up 2.6%

NYSE PACS opened at $49.08 on Thursday. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21. The firm has a 50 day moving average of $44.02 and a two-hundred day moving average of $39.72. The stock has a market capitalization of $7.77 billion, a PE ratio of 28.54, a price-to-earnings-growth ratio of 1.49 and a beta of -0.08. PACS Group has a 52 week low of $10.31 and a 52 week high of $50.38.

Insiders Place Their Bets

In other news, CEO Jason Murray sold 68,917 shares of PACS Group stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $48.60, for a total transaction of $3,349,366.20. Following the completion of the sale, the chief executive officer directly owned 54,188,200 shares in the company, valued at $2,633,546,520. The trade was a 0.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Joshua Jergensen sold 40,000 shares of the business's stock in a transaction that occurred on Wednesday, October 14th. The shares were sold at an average price of $44.50, for a total transaction of $1,780,000.00. Following the completion of the transaction, the chief operating officer directly owned 2,456,320 shares of the company's stock, valued at approximately $109,306,240. This represents a 1.60% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 1,313,332 shares of company stock worth $58,321,281. 70.10% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Zacks Research downgraded PACS Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, September 9th. Oppenheimer upped their target price on shares of PACS Group from $48.00 to $57.00 and gave the company an "outperform" rating in a report on Monday, August 10th. UBS Group raised their price target on PACS Group from $57.00 to $60.00 and gave the stock a "buy" rating in a report on Thursday, August 6th. JPMorgan Chase & Co. boosted their price target on PACS Group from $47.00 to $58.00 and gave the company an "overweight" rating in a research report on Friday, September 4th. Finally, Royal Bank Of Canada upped their price objective on shares of PACS Group from $52.00 to $57.00 and gave the stock an "outperform" rating in a research report on Thursday, August 6th. Five equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $58.80.

PACS Group Company Profile

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company's operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.